Man Group’s Anavex Life Sciences AVXL Stock Holding History

Man Group’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-55,223	Closed	-$197K	–	2388
2025 Q4	$197K	Buy	55,223 +30,838	+126%	+$189K	﹤0.01%	2129
2025 Q3	$217K	Buy	+24,385	New	+$247K	﹤0.01%	2087
2024 Q3	–	Sell	-10,685	Closed	-$45.1K	–	1966
2024 Q2	$45.1K	Buy	+10,685	New	+$43.2K	﹤0.01%	1985

Other funds holding AVXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Man Group's AVXL Position: Q1 2026 in Review

Man Group sold out of Anavex Life Sciences (AVXL) in Q1 2026, closing a stake of 55,223 shares — an estimated $197K sold.

Man Group first reported a position in AVXL in Q2 2024 and held it in 3 quarters. The position peaked at $217K in Q3 2025. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

Man Group reported no remaining Anavex Life Sciences position as of Q1 2026 after selling out during the quarter.
Man Group sold 55,223 Anavex Life Sciences shares in Q1 2026, an estimated $197K.
Man Group first reported a position in Anavex Life Sciences in Q2 2024 and held it in 3 quarters.
Man Group's Anavex Life Sciences position peaked at $217K in Q3 2025.
190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.